Amorfix Life Sciences Ltd. Announces Fiscal 2009 Second Quarter Results
TORONTO, Nov. 6 /CNW/ - Amorfix Life Sciences, a company focused on
treatments and diagnostics for brain wasting diseases, today announced its
operational and financial results for the three and six months ended September
30, 2008.